Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions

BACKGROUND: Aspirin is a primary antiplatelet agent for the secondary prevention of ischemic stroke. However, if aspirin fails to inhibit platelet function, as is expected in acute ischemic stroke (AIS), it may increase the rate of early clinical events. Therefore, we sought to determine whether asp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joon-Tae, Heo, Suk-Hee, Lee, Ji Sung, Choi, Min-Ji, Choi, Kang-Ho, Nam, Tai-Seung, Lee, Seung-Han, Park, Man-Seok, Kim, Byeong C., Kim, Myeong-Kyu, Cho, Ki-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388531/
https://www.ncbi.nlm.nih.gov/pubmed/25849632
http://dx.doi.org/10.1371/journal.pone.0120743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388531/
https://www.ncbi.nlm.nih.gov/pubmed/25849632
http://dx.doi.org/10.1371/journal.pone.0120743

Ejemplares similares